Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
TransCode Therapeutics Inc. (RNAZ) had Pre-Tax Income of $-6.75M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-6.87M |
|
-- |
|
-- |
|
$6.79M |
|
$-6.79M |
|
$0.04M |
|
|
Pre-Tax Income |
$-6.75M |
$-6.75M |
|
$-6.75M |
|
$-6.75M |
|
$-6.75M |
|
$-6.75M |
|
$-6.79M |
|
$-6.77M |
|
0.96M |
|
0.96M |
|
$-7.17 |
|
$-7.17 |
|
| Balance Sheet Financials | |
$10.64M |
|
$0.32M |
|
$140.37M |
|
$151.01M |
|
$5.40M |
|
-- |
|
$173.31M |
|
$178.71M |
|
$-27.70M |
|
$-167.74M |
|
$-27.69M |
|
1.01M |
|
| Cash Flow Statement Financials | |
$-10.38M |
|
-- |
|
$0.95M |
|
$17.81M |
|
$8.38M |
|
$-9.43M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.97 |
|
-- |
|
-- |
|
-- |
|
-0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
24.37% |
|
4.02% |
|
-4.47% |
|
24.37% |
|
$-27.38 |
|
$-10.84 |
|
$-10.84 |
|